Supplemention of maternal diet
View Patent ↗The use of probiotic bacteria in the manufacture of a composition for administration to a woman in at least the third trimester of pregnancy for prevention of gestational diabetes, normalizing plasma glucose concentration and/or increasing insulin sensitivity.
1. A method for reducing the risk of a condition associated with gestational diabetes mellitus in infant(s), the method comprising:
administering to a pregnant woman a therapeutically-effective amount of a composition comprising a probiotic mixture of Lactobacillus rhamnosus CGMCC 1.3724 and Bifidobacterium lactis CNCM 1-3446.
2. The method of claim 1 , wherein administration of the composition to the woman continues after delivery.
3. The method of claim 1 , wherein the composition is administered to provide the probiotic mixture in a daily dose of between 10 5 to 10 12 colony forming units.
4. The method of claim 1 , wherein the composition is administered to the woman for the second and third trimesters of pregnancy.
5. The method of claim 1 , wherein the composition is administered for the full duration of the pregnancy.
6. The method of claim 1 , wherein the composition is administered to the woman during at least the third trimester of pregnancy.
7. The method of claim 1 , wherein the condition associated with gestational diabetes mellitus is selected from the group consisting of overweight, juvenile diabetes, hypertension, and combinations thereof.